医学
乳腺癌
逻辑回归
多参数磁共振成像
接收机工作特性
乳房磁振造影
乳房成像
风险评估
放射科
磁共振成像
有效扩散系数
磁共振弥散成像
定量评估
曲线下面积
核医学
癌症
肿瘤科
乳腺摄影术
置信区间
前瞻性队列研究
乳腺组织
内科学
作者
Wesley Surento,Romy Fischer,Debosmita Biswas,Daniel S. Hippe,Anum S. Kazerouni,Jin You Kim,Isabella Li,John H. Gennari,Habib Rahbar,Savannah C. Partridge
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2025-11-26
卷期号:17 (23): 3771-3771
被引量:1
标识
DOI:10.3390/cancers17233771
摘要
Background/Objectives: This study explored the associations of normal breast tissue characteristics on multiparametric MRI with clinical assessments of breast cancer risk in women with dense breasts. Methods: Women with dense breasts who underwent multiparametric MRI were included. Breast cancer risk was determined based on Tyrer–Cuzick (TC) lifetime risk scores, categorized as high (TC ≥ 20%) or low risk. Qualitative background parenchymal enhancement (BPE) assessment was obtained from imaging reports. Quantitative imaging markers were calculated, including median BPE, median apparent diffusion coefficient, and volume measures of the whole breast, fibroglandular tissue (FGT), blood vessels, and BPE regions. The associations between imaging markers and TC risk groups were evaluated using age-adjusted logistic regression and summarized by area under the receiver operating characteristic curve (AUC). Results: Seventy-seven women were evaluated; a total of 20 (26%) were low risk, and 57 (74%) were high risk. After adjusting for age and multiple testing, BPE:breast ratio (adj. p = 0.037), FGT:breast ratio (adj. p = 0.046), and BPE:vessel ratio (adj. p = 0.037) were positively associated with risk, while qualitative BPE was not (adj. p = 0.11). Overall, risk categorizations based on imaging markers were concordant with TC score in up to 70% of women. Conclusions: In women with dense breasts, quantitative measures from multiparametric MRI (BPE:breast, FGT:breast, and BPE:vessel ratios) moderately discriminated high- and low-risk groups, warranting further investigation of their value to supplement conventional breast cancer risk assessment tools.
科研通智能强力驱动
Strongly Powered by AbleSci AI